Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT02428985 · COMPLETED

Trial details

NCT number: NCT02428985
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension, Pulmonary

Start date: 2015-06-29
Primary completion: 2023-04-17
Enrollment: 882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.